Status:

COMPLETED

Rejuvenate Modular Outcomes Study

Lead Sponsor:

Stryker Orthopaedics

Conditions:

Arthroplasty, Replacement, Hip

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study will be an evaluation of the Rejuvenate® Modular Hip System for primary total hip replacement (THR) with a cementless application in a consecutive series of patients who meet the eligibilit...

Eligibility Criteria

Inclusion

  • Patient has signed an IRB approved, study specific Informed Patient Consent Form.
  • Patient is a male or non-pregnant female age 18 years or older at time of study device implantation.
  • Patient has primary diagnosis of Non-Inflammatory Degenerative Joint Disease (NIDJD).
  • Patient is a candidate for a primary cementless total hip replacement.
  • Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.
  • Patient's operative femur templates to Rejuvenate® Modular Stem size 7-12.

Exclusion

  • Patient has a Body Mass Index (BMI) ≥ 40.
  • Patient has an active or suspected latent infection in or about the affected hip joint at time of study device implantation.
  • Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the device.
  • Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's Disease) leading to progressive bone deterioration.
  • Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. \> 30 days).
  • Patient requires revision surgery of a previously implanted total hip replacement or hip fusion to the affected joint.
  • Patient has a known sensitivity to device materials.
  • Patient is a prisoner.

Key Trial Info

Start Date :

November 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 20 2022

Estimated Enrollment :

42 Patients enrolled

Trial Details

Trial ID

NCT01257568

Start Date

November 1 2010

End Date

January 20 2022

Last Update

February 16 2022

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Oakwood Healthcare

Dearborn, Michigan, United States, 48124

2

St. Cloud Orthopaedics Associates

Sartell, Minnesota, United States, 56377

3

The Orthopedic Center

Tulsa, Oklahoma, United States, 74104

Rejuvenate Modular Outcomes Study | DecenTrialz